CELYAD ONCOLOGY SA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3035 EUR | 0.00% |
|
-2.10% | -22.18% |
| 04/04 | Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 09/02 | Celyad Oncology Seeks Termination of Reporting Obligations to US SEC | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 13.55M | - | - | - | - | - | |
| 46.4B | - | |||||
| 41.75B | ||||||
| 41.37B | ||||||
| 29.71B | ||||||
| 26.01B |
- Stock Market
- Equities
- CYAD Stock
- Charts Celyad Oncology SA
- Sector Chart